Curcumin

botanical

Curcumin is the main active polyphenol extracted from the rhizome of Curcuma longa, or turmeric. This yellow compound gives turmeric its color and many of its biological effects. It has been widely studied for its ability to reduce inflammation and oxidative stress at the cellular level. Its mechanisms involve modulating molecular targets including enzymes, transcription factors, and signaling pathways involved in inflammation and cellular defense. These effects make it a subject of research in areas such as joint comfort and cognitive function. Because curcumin typically has low bioavailability and is not easily absorbed, research focuses on enhancing its uptake. Formulations often include fats or other compounds to improve systemic availability so the body can better utilize its properties.

Natural sources
Turmeric (Curcuma longa)

Ingredient forms

No public comparison lists found.

Timing & Intake
AnytimeWith foodTake with Fats or oils to enhance absorption.
Taking curcumin with a meal containing fats significantly improves its absorption and bioavailability.
Optimal Dosage
Minimum500 mg
Maximum2000 mg
Safety & Toxicity
4 safety notes
  • Individuals with gallstones or bile duct obstruction should consult a healthcare professional before use, as curcumin can stimulate bile production.
  • May have mild blood-thinning effects; use with caution if you have a bleeding disorder or are scheduled for surgery.
  • Pregnant or breastfeeding individuals should consult a healthcare professional before use due to limited safety data.
  • May interact with certain medications; consult a healthcare professional if taking prescription drugs.
Goals
Anti-Aging
Impact
High effect
Typical dose:500–1500 mg
Standard curcumin has poor bioavailability. For effective results, it must be taken in an enhanced form (e.g., with piperine or as a phytosome complex), which significantly increases absorption. It works by inhibiting inflammatory molecules like NF-kB.

Study evidence

6 studies

Curcumin shows promise for selected aspects of healthy aging, including memory, mood and blood-vessel function in some older adults. The available evidence does not establish that it slows aging itself, extends lifespan or broadly prevents age-related disease.

View goal
Anti-Inflammatory Support
Impact
High effect
Typical dose:500–1500 mg
Curcumin, the active component in turmeric, is one of the most well-researched anti-inflammatory botanicals. It effectively reduces markers of inflammation like CRP and blocks enzymes such as COX-2. For clinical efficacy, it must be taken in a form with enhanced bioavailability, such as combined with piperine or formulated as a phytosome.

Study evidence

68 studies

Curcumin can reduce some markers of inflammation, particularly in people with inflammatory or metabolic conditions, but results vary substantially. Evidence for symptom improvement is condition-specific, and changes in blood markers do not establish a broad or lasting health benefit.

View goal
Cognitive Support
Impact
High effect
Typical dose:500–2000 mg
Curcumin has strong evidence for supporting long-term brain health through its potent anti-inflammatory mechanisms.

Study evidence

14 studies

Curcumin may improve some aspects of memory and thinking, but results are inconsistent across formulations and populations. The supplied research does not establish a dependable overall cognitive benefit or dementia prevention, and digestive side effects occur more often than with placebo.

View goal
Detoxification
Impact
High effect
Typical dose:500–1500 mg
Curcumin, especially in a bioavailable form (e.g., combined with piperine), activates the Nrf2 genetic pathway. This pathway switches on the production of numerous protective enzymes, including those involved in glutathione synthesis and conjugation, enhancing the body's overall detoxification capacity.

Study evidence

30 studies

Curcumin may improve some liver-health markers in people with fatty liver disease, but this is not evidence of general detoxification. Effects on liver fat and scarring are inconsistent, and the supplied research does not show that curcumin removes toxins from the body.

View goal
Digestive Health
Impact
High effect
Typical dose:500–1500 mg
Curcumin, the active compound in turmeric, is a potent inhibitor of NF-kB, a key driver of inflammation. While standard curcumin has poor bioavailability, formulations combined with piperine or other absorption enhancers are highly effective for reducing gut inflammation.

Study evidence

31 studies

Curcumin may relieve some digestive symptoms and improve ulcerative colitis outcomes when added to standard treatment. Benefits vary by condition and formulation, and the evidence does not establish broad improvements in the gut microbiome or reliable treatment of digestive infections.

View goal
General Health
Impact
High effect
Typical dose:500–1500 mg
Curcumin targets multiple inflammatory pathways in the body. However, standard curcumin is poorly absorbed. For effective results, it must be consumed in a form with enhanced bioavailability, such as one combined with piperine (black pepper extract) or formulated with phytosomes.

Study evidence

64 studies

Curcumin may improve selected metabolic markers, inflammatory measures, and symptoms in some health conditions. These benefits vary by outcome and formulation, and the available research does not establish a broad general-health benefit for everyone; some clinical settings show no benefit or unfavorable findings.

View goal
Showing 6 of 16 goals

Studies

Research connections will load here.
Sources

Up to five highest-ranked published examples per goal. Study counts and charts include all published studies for the connection.

  1. Further Evidence of Benefits to Mood and Working Memory from Lipidated Curcumin in Healthy Older People: A 12-Week, Double-Blind, Placebo-Controlled, Partial Replication Study.
    Cox KHM; White DJ; Pipingas A; Poorun K; Scholey A · Nutrients · 2021
    Randomized trial80 participantsAnti-Aging
  2. Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women.
    Akazawa N; Choi Y; Miyaki A; Tanabe Y; Sugawara J; Ajisaka R; Maeda S · Nutrition research (New York, N.Y.) · 2013
    Clinical trial32 participantsAnti-Aging
  3. A novel phospholipid delivery system of curcumin (Meriva®) preserves muscular mass in healthy aging subjects.
    Franceschi F; Feregalli B; Togni S; Cornelli U; Giacomelli L; Eggenhoffner R; Belcaro G · European review for medical and pharmacological sciences · 2016
    Non-randomized trial86 participantsAnti-Aging
  4. Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence.
    Nunes YC; Mendes NM; Pereira de Lima E; Chehadi AC; Lamas CB; Haber JFS; Dos Santos Bueno M; Araújo AC; Catharin VCS; Detregiachi CRP; Laurindo LF; Tanaka M; Barbalho SM; Marin MJS · Nutrients · 2024
    Systematic review15 studies pooledCognitive SupportAnti-Aging
  5. Curcumin and arterial function in health and disease: impact on oxidative stress and inflammation.
    Fleenor BS; Carlini NA; Campbell MS · Current opinion in clinical nutrition and metabolic care · 2020
    Narrative reviewAnti-Aging
  6. Effect of curcumin on inflammatory markers and disease activity in patients with rheumatoid arthritis: A meta-analysis.
    Zhang F; Niu B · Medicine · 2025
    Meta-analysis7 studies pooledAnti-Inflammatory Support
  7. Effect of curcumin on C-reactive protein as a biomarker of systemic inflammation: An updated meta-analysis of randomized controlled trials.
    Gorabi AM; Abbasifard M; Imani D; Aslani S; Razi B; Alizadeh S; Bagheri-Hosseinabadi Z; Sathyapalan T; Sahebkar A · Phytotherapy research : PTR · 2022
    Meta-analysis32 studies pooledAnti-Inflammatory Support
  8. Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials.
    Derosa G; Maffioli P; Simental-Mendía LE; Bo S; Sahebkar A · Pharmacological research · 2018
    Meta-analysis9 studies pooledAnti-Inflammatory Support
  9. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ · Nutrition & metabolism · 2024
    Randomized trial84 participantsCardiovascular SupportAnti-Inflammatory SupportDetoxification
  10. Is Curcumin Intake Really Effective for Chronic Inflammatory Metabolic Disease? A Review of Meta-Analyses of Randomized Controlled Trials.
    Lee YM; Kim Y · Nutrients · 2024
    Systematic review54 studies pooledAnti-Inflammatory Support
  11. Curcumin-Rich Curry Consumption Is Associated with Lower Risk of Cognitive Decline and Incidence of Mild Cognitive Impairment or Dementia: An Asian Population-Based Study.
    Lu Y; Lee TS; Lim WS; Yap P; Cheong CY; Rawtaer I; Liew TM; Gwee X; Gao Q; Yap KB; Ng TP · Nutrients · 2025
    Cohort study2,920 participantsBrain HealthCognitive Support
  12. The effect of curcumin supplementation on cognitive function: an updated systematic review and meta-analysis.
    Wang W; Zhao R; Liu B; Li K · Frontiers in nutrition · 2025
    Meta-analysis501 participants9 studies pooledCognitive Support
  13. Curcumin and Cognitive Health: Insights from Randomized Controlled Trials.
    Sivamaruthi BS; Chaiyasut C; Kesika P · Current pharmaceutical design · 2026
    Narrative reviewCognitive Support
  14. Botanicals and phytochemicals active on cognitive decline: The clinical evidence.
    Cicero AFG; Fogacci F; Banach M · Pharmacological research · 2019
    Systematic reviewCognitive Support
  15. Curcumin supplementation effect on liver enzymes in patients with nonalcoholic fatty liver disease: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.
    Vajdi M; Hassanizadeh S; Hassanizadeh R; Bagherniya M · Nutrition reviews · 2024
    Meta-analysis905 participants15 studies pooledDetoxification
  16. Therapeutic effects of curcumin supplementation on liver enzymes of nonalcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.
    Ebrahimzadeh A; Ebrahimzadeh A; Fooladshekan S; Mohseni S; Mohtashamian A; Babajafari S; Sohrabi Z · Food science & nutrition · 2025
    Meta-analysis14 studies pooledDetoxification
  17. Curcumin Attenuates Liver Steatosis via Antioxidant and Anti-Inflammatory Pathways in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
    Yaikwawong M; Kamdee K; Chuengsamarn S · International journal of molecular sciences · 2025
    Randomized trial227 participantsDetoxification
  18. A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study.
    T Krishnareddy N; Thomas JV; Nair SS; N Mulakal J; Maliakel BP; Krishnakumar IM · BioMed research international · 2019
    Randomized trial48 participantsDetoxification
  19. Curcuminoids for Metabolic Syndrome: Meta-Analysis Evidences Toward Personalized Prevention and Treatment Management.
    Nurcahyanti ADR; Cokro F; Wulanjati MP; Mahmoud MF; Wink M; Sobeh M · Frontiers in nutrition · 2022
    Meta-analysisDigestive Health
  20. [Curcumin in children with autism spectrum disorder: systemic inflammation, sensory regulation, and gut-brain interaction disorders. A randomized, double-blind, placebo-controlled clinical trial (CURATEA)].
    Vergara Serpa JJ; Sumalla Cano S · Nutricion hospitalaria · 2026
    Randomized trial60 participantsBrain HealthDigestive Health
  21. Curcumin supplementation during high-altitude exposure modulates body composition and its relationship with gut microbiota: a randomized controlled trial.
    Hu J; Fan D; Xiao C; Kang C; Shi J; Li Y; Liu J; Shen L; Lin N · Nutrition journal · 2026
    Randomized trial102 participantsDigestive Health
  22. Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.
    Abalo R; Gallego-Barceló P; Gabbia D · International journal of molecular sciences · 2025
    Randomized trialDigestive Health
  23. Turmeric for Treatment of Irritable Bowel Syndrome: A Systematic Review of Population-Based Evidence.
    Jafarzadeh E; Shoeibi S; Bahramvand Y; Nasrollahi E; Maghsoudi AS; Yazdi F; KarkonShayan S; Hassani S · Iranian journal of public health · 2022
    Systematic review9 studies pooledDigestive Health
  24. The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis.
    Sadeghi N; Mansoori A; Shayesteh A; Hashemi SJ · Phytotherapy research : PTR · 2020
    Randomized trial70 participantsGeneral Health
  25. The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial.
    Parohan M; Sarraf P; Javanbakht MH; Foroushani AR; Ranji-Burachaloo S; Djalali M · Nutritional neuroscience · 2021
    Randomized trial100 participantsGeneral Health
  26. Efficacy and Safety of a Novel Low-Dose Water-Dispersible Turmeric Extract in the Management of Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Thanawala S; Shah R; Alluri KV; Bhupathiraju K; Prasad N; Agarwal Y · Journal of pain research · 2025
    Randomized trial139 participantsGeneral Health
  27. Effectiveness of curcuminoids in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized clinical trials.
    Onakpoya IJ; Spencer EA; Perera R; Heneghan CJ · International journal of rheumatic diseases · 2018
    Meta-analysis797 participants7 studies pooledGeneral Health
  28. Effectiveness and safety of turmeric for the treatment of COVID-19: An updated systematic review and meta-analysis of randomized controlled trials.
    Sawangjit R; Sadoyu S; Manosanthipaibul S; Teerawattanapong N; Puttarak P; Wanaratna K; Charoensup R; Hiransai P; Meetam T; Chaiyakunapruk N · Complementary therapies in medicine · 2025
    Meta-analysis1,407 participants23 studies pooledGeneral Health
  29. The Effect of Curcumin Supplementation on Pulse Wave Velocity in Patients with Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Alidadi M; Sahebkar A; Eslami S; Vakilian F; Jarahi L; Alinezhad-Namaghi M; Arabi SM; Vakili S; Tohidinezhad F; Nikooiyan Y; Norouzy A · Advances in experimental medicine and biology · 2021
    Randomized trial66 participantsHeart Health
  30. The Effects of Nano-curcumin on Metabolic Status in Patients With Diabetes on Hemodialysis, a Randomized, Double Blind, Placebo-controlled Trial.
    Shafabakhsh R; Asemi Z; Reiner Z; Soleimani A; Aghadavod E; Bahmani F · Iranian journal of kidney diseases · 2021
    Randomized trial60 participantsHeart Health
  31. Curcumin supplementation improves the clinical outcomes of patients with diabetes and atherosclerotic cardiovascular risk.
    El-Rakabawy OM; Elkholy AA; Mahfouz AA; Abdelsalam MM; El Wakeel LM · Scientific reports · 2025
    Randomized trial72 participantsHeart Health
  32. Curcumin Nanomicelle Improves Lipid Profile, Stress Oxidative Factors and Inflammatory Markers in Patients Undergoing Coronary Elective Angioplasty; A Randomized Clinical Trial.
    Helli B; Gerami H; Kavianpour M; Heybar H; Hosseini SK; Haghighian HK · Endocrine, metabolic & immune disorders drug targets · 2022
    Randomized trial90 participantsCardiovascular SupportHeart Health
  33. The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial.
    Yaikwawong M; Jansarikit L; Jirawatnotai S; Chuengsamarn S · Nutrients · 2024
    Randomized trial227 participantsHeart Health
  34. Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis.
    Zhao J; Liang G; Zhou G; Hong K; Yang W; Liu J; Zeng L · Journal of ethnopharmacology · 2024
    Meta-analysis2,175 participants23 studies pooledJoint Health
  35. Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.
    Zeng L; Yang T; Yang K; Yu G; Li J; Xiang W; Chen H · Frontiers in immunology · 2022
    Meta-analysis2,396 participants29 studies pooledJoint Health
  36. The efficacy of curcumin in relieving osteoarthritis: A meta-analysis of meta-analyses.
    Bideshki MV; Jourabchi-Ghadim N; Radkhah N; Behzadi M; Asemani S; Jamilian P; Zarezadeh M · Phytotherapy research : PTR · 2024
    Meta-analysis11 studies pooledJoint Health
  37. The efficacy of high- and low-dose curcumin in knee osteoarthritis: A systematic review and meta-analysis.
    Hsiao AF; Lien YC; Tzeng IS; Liu CT; Chou SH; Horng YS · Complementary therapies in medicine · 2021
    Meta-analysis1,258 participants11 studies pooledJoint Health
  38. The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis.
    Zeng L; Yu G; Hao W; Yang K; Chen H · Bioscience reports · 2022
    Meta-analysis1,621 participants15 studies pooledJoint Health
  39. Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.
    Yaikwawong M; Jansarikit L; Jirawatnotai S; Chuengsamarn S · Nutrition journal · 2024
    Randomized trial272 participantsMetabolism Boost
  40. The effects of curcumin intake on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Mokhtari M; Razzaghi R; Momen-Heravi M · Phytotherapy research : PTR · 2021
    Randomized trial60 participantsMetabolism Boost
  41. Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Jamilian M; Foroozanfard F; Kavossian E; Aghadavod E; Shafabakhsh R; Hoseini A; Asemi Z · Clinical nutrition ESPEN · 2021
    Randomized trial60 participantsMetabolism Boost
  42. Effects of metformin and curcumin in women with polycystic ovary syndrome: A factorial clinical trial.
    Feghhi F; Ghaznavi H; Sheervalilou R; Razavi M; Sepidarkish M · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024
    Randomized trial200 participantsMetabolism Boost
  43. Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial.
    Cicero AFG; Sahebkar A; Fogacci F; Bove M; Giovannini M; Borghi C · European journal of nutrition · 2021
    Randomized trial80 participantsMetabolism Boost
  44. Effect and Safety of Phytosomal Curcumin Supplementation on Migraine Patients: A Randomized, Double-Blind and Placebo-Controlled Trial.
    Shojaei M; Khorvash F; Sahebkar A; Sathyapalan T; Bagherniya M · Chinese journal of integrative medicine · 2025
    Randomized trial70 participantsStress Relief
  45. Curcumin for depression: a meta-analysis.
    Fusar-Poli L; Vozza L; Gabbiadini A; Vanella A; Concas I; Tinacci S; Petralia A; Signorelli MS; Aguglia E · Critical reviews in food science and nutrition · 2020
    Meta-analysis531 participants9 studies pooledStress Relief
  46. Effect of curcumin supplementation on symptoms of anxiety: A systematic review and meta-analysis of randomized controlled trials.
    Fathi S; Agharloo S; Falahatzadeh M; Bahraminavid S; Homayooni A; Faghfouri AH; Shafiei D; Shafagh SG · Clinical nutrition ESPEN · 2024
    Meta-analysis567 participants8 studies pooledMood SupportStress Relief
  47. Efficacy of a curcumin extract (Curcugenâ„¢) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, double-blind, placebo-controlled study.
    Lopresti AL; Smith SJ; Rea A; Michel S · BMC complementary medicine and therapies · 2021
    Randomized trial79 participantsStress Relief
  48. The effect of curcumin on postpartum depression and anxiety in primiparous women: a double-blind randomized placebo-controlled clinical trial.
    Hamlbar EP; Mirghafourvand M; Shaseb E; Kamalifard M · BMC complementary medicine and therapies · 2025
    Randomized trial96 participantsStress Relief
  49. Short-term curcumin supplementation enhances serum brain-derived neurotrophic factor in adult men and women: a systematic review and dose-response meta-analysis of randomized controlled trials.
    Sarraf P; Parohan M; Javanbakht MH; Ranji-Burachaloo S; Djalali M · Nutrition research (New York, N.Y.) · 2020
    Meta-analysis139 participants4 studies pooledBrain Health
  50. Curcumin-Rich Curry Consumption and Neurocognitive Function from 4.5-Year Follow-Up of Community-Dwelling Older Adults (Singapore Longitudinal Ageing Study).
    Ng TP; Nyunt MSZ; Gao Q; Gwee X; Chua DQL; Yap KB · Nutrients · 2022
    Cohort study2,734 participantsBrain Health
  51. The effects of oral administration of curcumin-galactomannan complex on brain waves are consistent with brain penetration: a randomized, double-blinded, placebo-controlled pilot study.
    Khanna A; Das S S; Kannan R; Swick AG; Matthewman C; Maliakel B; Ittiyavirah SP; Krishnakumar IM · Nutritional neuroscience · 2022
    Randomized trial18 participantsBrain Health
  52. Effects of Curcumin on Bone Loss and Biochemical Markers of Bone Turnover in Patients with Spinal Cord Injury.
    Hatefi M; Ahmadi MRH; Rahmani A; Dastjerdi MM; Asadollahi K · World neurosurgery · 2018
    Non-randomized trial100 participantsBone Health
  53. The Effect of Selected Herbal Medicines on Bone Turnover Markers: A Systematic Review and Meta-Analysis.
    Kheiridoost-Langaroodi H; Shakouri SK; Amirpour M; Iranshahi AM; Farshbaf-Khalili A · Journal of family & reproductive health · 2022
    Meta-analysis968 participants16 studies pooledBone Health
  54. Efficacy of nanomicelle curcumin, Nigella sativa oil, and their combination on bone turnover markers and their safety in postmenopausal women with primary osteoporosis and osteopenia: A triple-blind randomized controlled trial.
    Kheiridoost H; Shakouri SK; Shojaei-Zarghani S; Dolatkhah N; Farshbaf-Khalili A · Food science & nutrition · 2023
    Randomized trial120 participantsBone Health
  55. The Effect of Curcumin on Postmenopausal Symptoms: A Systematic Review Based on Randomized Controlled Trials.
    Akyakar B; Şahin İN; Ağagündüz D; Szép D; Budán F · International journal of molecular sciences · 2025
    Systematic review12 studies pooledBone Health
  56. Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study.
    Riva A; Togni S; Giacomelli L; Franceschi F; Eggenhoffner R; Feragalli B; Belcaro G; Cacchio M; Shu H; Dugall M · European review for medical and pharmacological sciences · 2017
    Non-randomized trial57 participantsBone Health
  57. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials.
    Qin S; Huang L; Gong J; Shen S; Huang J; Ren H; Hu H · Nutrition journal · 2018
    Meta-analysis649 participants7 studies pooledCardiovascular Support
  58. Effects of nanocurcumin supplementation on metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Wilar G; Suhandi C; Fukunaga K; Shigeno M; Kawahata I; Abdulah R; Sasaki T · Pharmacological research · 2025
    Meta-analysis1,394 participants20 studies pooledCardiovascular Support
  59. The Effects of Curcumin on Glycemic Control and Lipid Profiles Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Metaanalysis of Randomized Controlled Trials.
    Tabrizi R; Vakili S; Lankarani KB; Akbari M; Mirhosseini N; Ghayour-Mobarhan M; Ferns G; Karamali F; Karamali M; Taghizadeh M; Kouchaki E; Asemi Z · Current pharmaceutical design · 2019
    Meta-analysis1,890 participants26 studies pooledCardiovascular Support
  60. The effect of curcumin supplementation on delayed-onset muscle soreness, inflammation, muscle strength, and joint flexibility: A systematic review and dose-response meta-analysis of randomized controlled trials.
    Beba M; Mohammadi H; Clark CCT; Djafarian K · Phytotherapy research : PTR · 2022
    Meta-analysis10 studies pooledFitness
  61. The Effects of Curcumin Supplementation on Muscle Damage, Oxidative Stress, and Inflammatory Markers in Healthy Females with Moderate Physical Activity: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Salehi M; Mashhadi NS; Esfahani PS; Feizi A; Hadi A; Askari G · International journal of preventive medicine · 2023
    Randomized trial80 participantsFitness
  62. Modulation of Exercise-Induced Muscle Damage, Inflammation, and Oxidative Markers by Curcumin Supplementation in a Physically Active Population: A Systematic Review.
    Fernández-Lázaro D; Mielgo-Ayuso J; Seco Calvo J; Córdova Martínez A; Caballero García A; Fernandez-Lazaro CI · Nutrients · 2020
    Systematic review11 studies pooledFitness
  63. Effects of Turmeric Concentrate on Cardiovascular Risk Factors and Exercise-Induced Oxidative Stress in Healthy Volunteers; an Exploratory Study.
    Hajleh MNA; Al-Dujaili EAS · Advanced pharmaceutical bulletin · 2023
    Randomized trial22 participantsFitness
  64. Effects of curcumin supplementation on sport and physical exercise: a systematic review.
    Suhett LG; de Miranda Monteiro Santos R; Silveira BKS; Leal ACG; de Brito ADM; de Novaes JF; Lucia CMD · Critical reviews in food science and nutrition · 2021
    Systematic review11 studies pooledFitness
  65. Effect of curcumin on nasal symptoms and airflow in patients with perennial allergic rhinitis.
    Wu S; Xiao D · Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2017
    Randomized trial241 participantsImmunity
  66. Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study.
    Kuwabara Y; Hirose A; Lee H; Kakinuma T; Baba A; Takara T · Journal of dietary supplements · 2023
    Randomized trial99 participantsImmunity
  67. Effects of curcumin-piperine supplementation on systemic immunity in young women with premenstrual syndrome and dysmenorrhea: A randomized clinical trial.
    Bahrami A; Mohammadifard M; Rajabi Z; Motahari-Nasab M; Ferns GA · European journal of obstetrics, gynecology, and reproductive biology · 2022
    Randomized trial80 participantsImmunity
  68. The roles of curcumin in regulating the tumor immunosuppressive microenvironment.
    Wang Y; Lu J; Jiang B; Guo J · Oncology letters · 2020
    Narrative reviewImmunity
  69. Neuroprotective Activities of Curcumin in Parkinson's Disease: A Review of the Literature.
    Nebrisi EE · International journal of molecular sciences · 2021
    Narrative reviewImmunity
  70. Clinical Use of Curcumin in Depression: A Meta-Analysis.
    Ng QX; Koh SSH; Chan HW; Ho CYX · Journal of the American Medical Directors Association · 2018
    Meta-analysis377 participants6 studies pooledMood Support
  71. Efficacy of curcumin in depression: A grade-assessed systematic review and meta-analysis of randomized controlled trials.
    Musazadeh V; Faghfouri AH; Falahatzadeh M; Mahmoudinezhad M; Alizadeh M; Shidfar F · Annals of general psychiatry · 2026
    Meta-analysis19 studies pooledMood Support
  72. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study.
    Lopresti AL; Maes M; Maker GL; Hood SD; Drummond PD · Journal of affective disorders · 2015
    Randomized trial56 participantsMood Support
  73. Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study.
    Kanchanatawan B; Tangwongchai S; Sughondhabhirom A; Suppapitiporn S; Hemrunrojn S; Carvalho AF; Maes M · Neurotoxicity research · 2018
    Randomized trial65 participantsMood Support